Superiority of intranasal over systemic administration of bioengineered soluble ACE2 for survival and brain protection against SARS-CoV-2 infection
与全身给药相比,鼻内给药生物工程可溶性ACE2在提高SARS-CoV-2感染患者的存活率和保护大脑方面更具优势
期刊:
影响因子:
doi:10.1101/2022.12.05.519032
Hassler, Luise; Wysocki, Jan; Ahrendsen, Jared T; Ye, Minghao; Gelarden, Ian; Nicolaescu, Vlad; Tomatsidou, Anastasia; Gula, Haley; Cianfarini, Cosimo; Khurram, Nigar; Kanwar, Yashpal; Singer, Benjamin D; Randall, Glenn; Missiakas, Dominique; Henkin, Jack; Batlle, Daniel